141 related articles for article (PubMed ID: 38852572)
21. Primary adenocarcinoma of cervical esophagus.
Alrawi SJ; Winston J; Tan D; Gibbs J; Loree TR; Hicks W; Rigual N; Lorè JM
J Exp Clin Cancer Res; 2005 Jun; 24(2):325-30. PubMed ID: 16110768
[TBL] [Abstract][Full Text] [Related]
22. Adenocarcinoma in Barrett's esophagus after elimination of gastroesophageal reflux.
Hamilton SR; Hutcheon DF; Ravich WJ; Cameron JL; Paulson M
Gastroenterology; 1984 Feb; 86(2):356-60. PubMed ID: 6690363
[TBL] [Abstract][Full Text] [Related]
23. Expression profiles of cancer stem cell markers: CD133, CD44, Musashi-1 and EpCAM in the cardiac mucosa-Barrett's esophagus-early esophageal adenocarcinoma-advanced esophageal adenocarcinoma sequence.
Mokrowiecka A; Veits L; Falkeis C; Musial J; Kordek R; Lochowski M; Kozak J; Wierzchniewska-Lawska A; Vieth M; Malecka-Panas E
Pathol Res Pract; 2017 Mar; 213(3):205-209. PubMed ID: 28216140
[TBL] [Abstract][Full Text] [Related]
24. Barrett's esophagus.
Falk GW
Gastroenterology; 2002 May; 122(6):1569-91. PubMed ID: 12016424
[TBL] [Abstract][Full Text] [Related]
25. Expression of the putative stem cell marker Musashi-1 in Barrett's esophagus and esophageal adenocarcinoma.
Bobryshev YV; Freeman AK; Botelho NK; Tran D; Levert-Mignon AJ; Lord RV
Dis Esophagus; 2010 Sep; 23(7):580-9. PubMed ID: 20459440
[TBL] [Abstract][Full Text] [Related]
26. Small cell carcinoma arising in Barrett's esophagus: a case report and review of the literature.
Markogiannakis H; Theodorou D; Toutouzas KG; Larentzakis A; Pattas M; Bousiotou A; Papacostas P; Filis K; Katsaragakis S
J Med Case Rep; 2008 Jan; 2():15. PubMed ID: 18211708
[TBL] [Abstract][Full Text] [Related]
27. Risk factors, DNA damage, and disease progression in Barrett's esophagus.
Olliver JR; Hardie LJ; Gong Y; Dexter S; Chalmers D; Harris KM; Wild CP
Cancer Epidemiol Biomarkers Prev; 2005 Mar; 14(3):620-5. PubMed ID: 15767340
[TBL] [Abstract][Full Text] [Related]
28. Adenocarcinoma of Cervical Esophagus Arising in the Barrett's Mucosa.
Sundriyal D; Shirsi N; Kotwal S; Kumar S; Mithran Parthasarthy K; Gupta M
Indian J Surg Oncol; 2015 Jun; 6(2):127-9. PubMed ID: 26405420
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA Profiles of Barrett's Esophagus and Esophageal Adenocarcinoma: Differences in Glandular Non-native Epithelium.
Drahos J; Schwameis K; Orzolek LD; Hao H; Birner P; Taylor PR; Pfeiffer RM; Schoppmann SF; Cook MB
Cancer Epidemiol Biomarkers Prev; 2016 Mar; 25(3):429-37. PubMed ID: 26604271
[TBL] [Abstract][Full Text] [Related]
30. Reflux, Barrett's Esophagus, and Esophageal Adenocarcinoma After Bariatric Surgery.
Medina B; Molena D
Foregut; 2021 Dec; 1(4):393-400. PubMed ID: 38646141
[TBL] [Abstract][Full Text] [Related]
31. Photodynamic therapy in Barrett's esophagus: reduction of specialized mucosa, ablation of dysplasia, and treatment of superficial esophageal cancer.
Overholt BF; Panjehpour M
Semin Surg Oncol; 1995; 11(5):372-6. PubMed ID: 7569560
[TBL] [Abstract][Full Text] [Related]
32.
Fang HY; Münch NS; Schottelius M; Ingermann J; Liu H; Schauer M; Stangl S; Multhoff G; Steiger K; Gerngroß C; Jesinghaus M; Weichert W; Kühl AA; Sepulveda AR; Wester HJ; Wang TC; Quante M
Clin Cancer Res; 2018 Mar; 24(5):1048-1061. PubMed ID: 29208671
[No Abstract] [Full Text] [Related]
33. Barrett's esophagus: pathogenesis, epidemiology, functional abnormalities, malignant degeneration, and surgical management.
Stein HJ; Siewert JR
Dysphagia; 1993; 8(3):276-88. PubMed ID: 8359051
[TBL] [Abstract][Full Text] [Related]
34. Multiple early esophageal cancers arising from Barrett's esophagus, and a review of cases of early adenocarcinoma in Barrett's esophagus in Japan.
Itatsu T; Miwa H; Murai T; Terai T; Ohkura R; Sorimachi S; Yang SW; Ogihara T; Watanabe S; Hirai S; Sato N
J Gastroenterol; 1997 Jun; 32(3):389-95. PubMed ID: 9213255
[TBL] [Abstract][Full Text] [Related]
35. No association between hOGG1, XRCC1, and XPD polymorphisms and risk of reflux esophagitis, Barrett's esophagus, or esophageal adenocarcinoma: results from the factors influencing the Barrett's adenocarcinoma relationship case-control study.
Ferguson HR; Wild CP; Anderson LA; Murphy SJ; Johnston BT; Murray LJ; Watson RG; McGuigan J; Reynolds JV; Hardie LJ
Cancer Epidemiol Biomarkers Prev; 2008 Mar; 17(3):736-9. PubMed ID: 18349297
[TBL] [Abstract][Full Text] [Related]
36. Esophageal adenocarcinoma arising from Barrett's epithelium in Taiwan.
Tu CH; Lee CT; Perng DS; Chang CC; Hsu CH; Lee YC
J Formos Med Assoc; 2007 Aug; 106(8):664-8. PubMed ID: 17711800
[TBL] [Abstract][Full Text] [Related]
37. A complete response to S-1 plus cis-diamminedichloroplatinum in advanced-stage esophageal and gastric adenocarcinoma: a case report.
Matsuno Y; Kochi M; Fujii M; Kanamori N; Kaiga T; Mihara Y; Funada T; Miyazaki T; Takayama T
World J Surg Oncol; 2012 Jul; 10():133. PubMed ID: 22759597
[TBL] [Abstract][Full Text] [Related]
38. Adenocarcinoma arising from heterotopic gastric mucosa in the cervical esophagus and upper thoracic esophagus: two case reports and literature review.
Kadota T; Fujii S; Oono Y; Imajoh M; Yano T; Kaneko K
Expert Rev Gastroenterol Hepatol; 2016; 10(3):405-14. PubMed ID: 26610162
[TBL] [Abstract][Full Text] [Related]
39. Esophageal adenocarcinoma arising from Barrett's dysplasia: a case report of double occurrence and prolonged survival after chemotherapy.
Vats HS; Banerjee TK; Resnick J; Khan Q
Clin Med Res; 2006 Sep; 4(3):184-8. PubMed ID: 16988098
[TBL] [Abstract][Full Text] [Related]
40. Hiatal hernia size, Barrett's length, and severity of acid reflux are all risk factors for esophageal adenocarcinoma.
Avidan B; Sonnenberg A; Schnell TG; Chejfec G; Metz A; Sontag SJ
Am J Gastroenterol; 2002 Aug; 97(8):1930-6. PubMed ID: 12190156
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
